These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 38462040)
1. Non-coding RNAs in diabetic peripheral neuropathy: their role and mechanisms underlying their effects. He Y; Qu L Metabolism; 2024 May; 154():155833. PubMed ID: 38462040 [TBL] [Abstract][Full Text] [Related]
2. [Experimental research progress in traditional Chinese medicine prevention and treatment of diabetic peripheral neuropathy based on autophagy]. Huang SS; Wang XR; Yuan JS; DU L Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(23):6315-6323. PubMed ID: 38211988 [TBL] [Abstract][Full Text] [Related]
3. Oxidative Stress in Diabetic Peripheral Neuropathy: Pathway and Mechanism-Based Treatment. Lin Q; Li K; Chen Y; Xie J; Wu C; Cui C; Deng B Mol Neurobiol; 2023 Aug; 60(8):4574-4594. PubMed ID: 37115404 [TBL] [Abstract][Full Text] [Related]
4. Biological Functions and Clinical Prospects of Extracellular Non-Coding RNAs in Diabetic Cardiomyopathy: an Updated Review. Yin Z; Chen C J Cardiovasc Transl Res; 2022 Jun; 15(3):469-476. PubMed ID: 35175553 [TBL] [Abstract][Full Text] [Related]
6. Long Non-coding RNA XIST Attenuates Diabetic Peripheral Neuropathy by Inducing Autophagy Through MicroRNA-30d-5p/ Liu BY; Li L; Bai LW; Xu CS Front Mol Biosci; 2021; 8():655157. PubMed ID: 33996907 [TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs: The potential biomarker or therapeutic target in hepatic ischemia-reperfusion injury. Shao JL; Wang LJ; Xiao J; Yang JF World J Gastroenterol; 2023 Sep; 29(33):4927-4941. PubMed ID: 37731999 [TBL] [Abstract][Full Text] [Related]
8. Non-Coding RNAs: New Biomarkers and Therapeutic Targets for Temporal Lobe Epilepsy. Manna I; Fortunato F; De Benedittis S; Sammarra I; Bertoli G; Labate A; Gambardella A Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328484 [TBL] [Abstract][Full Text] [Related]
9. Novel and Emerging Electrophysiological Biomarkers of Diabetic Neuropathy and Painful Diabetic Neuropathy. Marshall A; Alam U; Themistocleous A; Calcutt N; Marshall A Clin Ther; 2021 Sep; 43(9):1441-1456. PubMed ID: 33906790 [TBL] [Abstract][Full Text] [Related]
10. Progress in the treatment of diabetic peripheral neuropathy. Yang K; Wang Y; Li YW; Chen YG; Xing N; Lin HB; Zhou P; Yu XP Biomed Pharmacother; 2022 Apr; 148():112717. PubMed ID: 35193039 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of NAD+ metabolism-related biomarkers in patients with diabetic peripheral neuropathy. Ye C; Fu Y; Zhou X; Zhou F; Zhu X; Chen Y Front Endocrinol (Lausanne); 2024; 15():1309917. PubMed ID: 38464965 [TBL] [Abstract][Full Text] [Related]
12. Non-coding RNAs and exosomal non-coding RNAs in diabetic retinopathy: A narrative review. Zhong Y; Xia J; Liao L; Momeni MR Int J Biol Macromol; 2024 Feb; 259(Pt 1):128182. PubMed ID: 37977468 [TBL] [Abstract][Full Text] [Related]
13. Microarray analyses of lncRNAs and mRNAs expression profiling associated with diabetic peripheral neuropathy in rats. Guo G; Ren S; Kang Y; Liu Y; Duscher D; Machens HG; Chen Z J Cell Biochem; 2019 Sep; 120(9):15347-15359. PubMed ID: 31025414 [TBL] [Abstract][Full Text] [Related]
14. Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease. Li C; Wang D; Jiang Z; Gao Y; Sun L; Li R; Chen M; Lin C; Liu D Front Endocrinol (Lausanne); 2022; 13():961802. PubMed ID: 36147580 [TBL] [Abstract][Full Text] [Related]
15. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. Rolim LC; da Silva EM; Flumignan RL; Abreu MM; Dib SA Cochrane Database Syst Rev; 2019 Jun; 6(6):CD011265. PubMed ID: 31201734 [TBL] [Abstract][Full Text] [Related]
16. Advances in Computational Methodologies for Classification and Sub-Cellular Locality Prediction of Non-Coding RNAs. Asim MN; Ibrahim MA; Imran Malik M; Dengel A; Ahmed S Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445436 [TBL] [Abstract][Full Text] [Related]
17. Association Between Tumor Necrosis Factor-α and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes: a Meta-Analysis. Mu ZP; Wang YG; Li CQ; Lv WS; Wang B; Jing ZH; Song XJ; Lun Y; Qiu MY; Ma XL Mol Neurobiol; 2017 Mar; 54(2):983-996. PubMed ID: 26797519 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation in myocardial infarction: Non-coding RNAs and exosomal non-coding RNAs. Fadaei S; Zarepour F; Parvaresh M; Motamedzadeh A; Tamehri Zadeh SS; Sheida A; Shabani M; Hamblin MR; Rezaee M; Zarei M; Mirzaei H Front Cardiovasc Med; 2022; 9():1014961. PubMed ID: 36440025 [TBL] [Abstract][Full Text] [Related]
19. How inflammation dictates diabetic peripheral neuropathy: An enlightening review. Cheng Y; Chen Y; Li K; Liu S; Pang C; Gao L; Xie J; Wenjing LV; Yu H; Deng B CNS Neurosci Ther; 2024 Apr; 30(4):e14477. PubMed ID: 37795833 [TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV alleviates Schwann cell injury in diabetic peripheral neuropathy by regulating microRNA-155-mediated autophagy. Yin Y; Qu H; Yang Q; Fang Z; Gao R Phytomedicine; 2021 Nov; 92():153749. PubMed ID: 34601220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]